Stocks ORLY Financial statements
Financial statementsO REILLY AUTOMOTIVE INC financial statements
Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data O REILLY AUTOMOTIVE INC files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8,593 | 8,978 | 9,536 | 10,150 | 11,604 | 13,328 | 14,410 | 15,812 | 16,708 | 17,782 |
| Cost of revenue | 4,084 | 4,257 | 4,496 | 4,755 | 5,519 | 6,308 | 7,028 | 7,707 | 8,154 | 8,608 |
| Gross profit | 4,509 | 4,721 | 5,040 | 5,395 | 6,086 | 7,020 | 7,382 | 8,105 | 8,554 | 9,174 |
| Selling, general and administrative | 2,810 | 2,995 | 3,225 | 3,474 | 3,666 | 4,103 | 4,427 | 4,918 | 5,303 | 5,714 |
| Operating income | 1,699 | 1,725 | 1,815 | 1,921 | 2,419 | 2,917 | 2,954 | 3,186 | 3,251 | 3,461 |
| Interest expense | 70.9 | 91.3 | 122 | 140 | 161 | 145 | 158 | 202 | 223 | 235 |
| Other non-operating income | -62 | -87.6 | -121 | -130 | -153 | -135 | -156 | -182 | -206 | -220 |
| Pre-tax income | 1,637 | 1,638 | 1,694 | 1,790 | 2,266 | 2,782 | 2,799 | 3,005 | 3,045 | 3,240 |
| Income tax | 600 | 504 | 370 | 399 | 514 | 617 | 626 | 658 | 658 | 702 |
| Net income | 1,038 | 1,134 | 1,324 | 1,391 | 1,752 | 2,165 | 2,173 | 2,347 | 2,387 | 2,538 |
| EBITDA | 1,917 | 1,959 | 2,074 | 2,192 | 2,734 | 3,245 | 3,312 | 3,595 | 3,713 | 3,972 |
| EPS, basic | 0.72 | 0.85 | 1.08 | 1.20 | 1.58 | 2.09 | 2.25 | 2.59 | 2.73 | 2.98 |
| EPS, diluted | 0.71 | 0.84 | 1.07 | 1.19 | 1.57 | 2.07 | 2.23 | 2.56 | 2.71 | 2.97 |
| Shares, basic (weighted) | 1,434 | 1,329 | 1,223 | 1,157 | 1,109 | 1,036 | 967 | 907 | 875 | 851 |
| Shares, diluted (weighted) | 1,453 | 1,345 | 1,236 | 1,169 | 1,119 | 1,046 | 976 | 915 | 881 | 856 |
Balance sheet
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 147 | 46.3 | 31.3 | 40.4 | 466 | 362 | 109 | 279 | 130 | 194 |
| Receivables | 197 | 216 | 192 | 215 | 230 | 273 | 343 | 375 | 357 | 390 |
| Inventory | 2,779 | 3,010 | 3,193 | 3,454 | 3,653 | 3,686 | 4,359 | 4,658 | 5,096 | 5,731 |
| Other current assets | 53 | 49 | 48.3 | 44.8 | 50.7 | 70.1 | 110 | 105 | 118 | 269 |
| Total current assets | 3,258 | 3,398 | 3,543 | 3,834 | 4,500 | 4,504 | 5,048 | 5,558 | 5,840 | 6,744 |
| Property, plant and equipment | 3,123 | 3,344 | 3,587 | 3,948 | 4,095 | 4,214 | 4,424 | 5,037 | 5,605 | 6,257 |
| Lease right-of-use assets | 0 | 1,928 | 1,995 | 1,982 | 2,112 | 2,201 | 2,325 | 2,391 | ||
| Goodwill | 785 | 789 | 807 | 937 | 881 | 879 | 884 | 898 | 930 | 948 |
| Intangible assets | 11.3 | 9.39 | 8.44 | 1.79 | 56.3 | 49.2 | 46.2 | 49.8 | 67.9 | 71.7 |
| Other non-current assets | 37.4 | 41.3 | 43.4 | 70.1 | 126 | 139 | 159 | 179 | 194 | 197 |
| Total assets | 7,204 | 7,572 | 7,981 | 10,717 | 11,597 | 11,719 | 12,628 | 13,873 | 14,894 | 16,538 |
| Accounts payable | 2,937 | 3,190 | 3,376 | 3,605 | 4,185 | 4,695 | 5,881 | 6,092 | 6,525 | 7,104 |
| Short-term debt | 0 | 0 | ||||||||
| Total current liabilities | 3,401 | 3,647 | 3,894 | 4,469 | 5,262 | 5,875 | 7,064 | 7,661 | 8,284 | 8,776 |
| Long-term debt | 1,887 | 2,978 | 3,417 | 3,891 | 4,123 | 3,827 | 4,372 | 5,570 | 5,521 | 6,017 |
| Lease liabilities | 0 | 1,655 | 1,719 | 1,702 | 1,807 | 1,881 | 1,981 | 2,035 | ||
| Other non-current liabilities | 199 | 208 | 210 | 171 | 196 | 207 | 201 | 204 | 232 | 263 |
| Total liabilities | 5,577 | 6,919 | 7,627 | 10,320 | 11,456 | 11,785 | 13,689 | 15,612 | 16,265 | 17,302 |
| Total debt | 1,900 | 2,978 | 3,417 | 3,891 | 4,123 | 3,827 | 4,372 | 5,570 | 5,521 | 6,017 |
| Paid-in capital | 1,337 | 1,265 | 1,262 | 1,281 | 1,281 | 1,306 | 1,311 | 1,352 | 1,455 | 1,530 |
| Retained earnings | 290 | -613 | -909 | -889 | -1,139 | -1,366 | -2,376 | -3,132 | -2,791 | -2,329 |
| Other comprehensive income | 0 | 4.89 | -2.16 | -6.8 | 3 | 39.4 | -42.8 | 26.8 | ||
| Shareholders' equity | 1,627 | 653 | 354 | 397 | 140 | -66.4 | -1,061 | -1,739 | -1,371 | -763 |
| Total equity | 1,627 | 653 | 354 | 397 | 140 | -66.4 | -1,061 | -1,739 | -1,371 | -763 |
| Total liabilities and equity | 7,204 | 7,572 | 7,981 | 10,717 | 11,597 | 11,719 | 12,628 | 13,873 | 14,894 | 16,538 |
| Shares outstanding | 1,395 | 1,267 | 1,188 | 1,136 | 1,069 | 1,007 | 937 | 59.1 | 862 | 842 |
Cash flow statement
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income | 1,038 | 1,134 | 1,324 | 1,391 | 1,752 | 2,165 | 2,173 | 2,347 | 2,387 | 2,538 |
| Depreciation and amortization | 218 | 234 | 259 | 271 | 315 | 328 | 358 | 409 | 462 | 511 |
| Stock-based compensation | 18.9 | 19.4 | 20.2 | 21.9 | 22.7 | 24.7 | 26.5 | 27.5 | 28.9 | 35.1 |
| Deferred income tax | 10.4 | -4.76 | 20.2 | 21.2 | 12.4 | 20.4 | 69.6 | 48.2 | -49.8 | -37.5 |
| Change in receivables | -38.5 | -27.7 | 18.1 | -15.6 | -20.5 | -47.4 | -75.9 | -35.5 | 30.5 | -35.5 |
| Change in inventory | -119 | -232 | -163 | -240 | -199 | -32.6 | -669 | -288 | -404 | -605 |
| Change in payables | 322 | 253 | 178 | 213 | 581 | 511 | 1,185 | 207 | 421 | 576 |
| Cash from operations | 1,511 | 1,404 | 1,728 | 1,708 | 2,837 | 3,207 | 3,148 | 3,034 | 3,050 | 2,762 |
| Capital expenditures | -476 | -466 | -504 | -628 | -466 | -443 | -563 | -1,006 | -1,023 | -1,169 |
| Cash from investing | -529 | -464 | -534 | -797 | -615 | -616 | -740 | -996 | -1,167 | -1,152 |
| Debt issued | 499 | 749 | 499 | 500 | 998 | 0 | 847 | 750 | 499 | 0 |
| Debt repaid | 0 | 0 | -500 | -300 | -300 | -300 | 0 | 0 | ||
| Share buybacks | -1,505 | -2,173 | -1,714 | -1,433 | -2,087 | -2,476 | -3,282 | -3,151 | -2,077 | -2,097 |
| Cash from financing | -951 | -1,040 | -1,208 | -903 | -1,797 | -2,695 | -2,663 | -1,869 | -2,030 | -1,549 |
| Exchange rate effect | 0 | 0 | 0.17 | 0.1 | -0.36 | |||||
| Net change in cash | 30.3 | -100 | -15 | 9.09 | 425 | -104 | -254 | 171 | -149 | 63.5 |
| Free cash flow | 1,034 | 938 | 1,223 | 1,080 | 2,371 | 2,764 | 2,585 | 2,028 | 2,026 | 1,593 |
| Interest paid | 63.6 | 77.8 | 118 | 135 | 160 | 144 | 156 | 190 | 209 | 227 |
| Income taxes paid | 570 | 497 | 311 | 395 | 305 | 451 | 415 | 315 | 640 | 1,068 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 51.6% | Gross profit / revenue. |
| Operating margin | 19.6% | Operating income / revenue. |
| EBITDA margin | 22.5% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 18.3% | Pre-tax income / revenue. |
| Net margin | 14.3% | Net income / revenue. |
| FCF margin | 11.6% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 17.7% | Cash from operations / revenue. |
| Effective tax rate | 22.0% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on assets (ROA) | 15.2% | Net income / average total assets. |
| Return on invested capital (ROIC) | 57.6% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| SG&A / revenue | 32.1% | Selling, general and administrative expense / revenue. |
| Stock-based pay / revenue | 0.2% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 6.1% | Capital expenditures / revenue. |
| D&A / revenue | 2.9% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 6.4% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 7.3% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 8.9% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 7.2% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 7.5% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 8.6% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | 6.4% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | 5.4% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income CAGR, 5y | 7.4% | Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EBITDA growth, 1y | 7.0% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | 6.2% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA CAGR, 5y | 7.8% | Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Net income growth, 1y | 6.3% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | 5.3% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income CAGR, 5y | 7.7% | Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EPS growth, 1y | 9.6% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | 10.1% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS CAGR, 5y | 13.7% | Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | -9.4% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | -4.3% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | -0.5% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | -21.4% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | -14.9% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow CAGR, 5y | -7.6% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 11.0% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 9.4% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 7.4% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | -2.8% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | -4.3% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | -5.2% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 0.75x | Current assets / current liabilities. |
| Quick ratio | 0.08x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.03x | (Cash + short-term investments) / current liabilities. |
| Debt / assets | 40.3% | Total debt / total assets. |
| Liabilities / assets | 110.6% | Total liabilities / total assets. |
| Net debt | $6.75B | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Net debt / EBITDA | 1.62x | Net debt / EBITDA (twelve months), when EBITDA is positive. |
| Interest coverage | 14.4x | Operating income / interest expense. |
| Working capital | -$2.38B | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 5.5% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | -$2.79B | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 1.07x | Revenue / average total assets. |
| Fixed asset turnover | 2.84x | Revenue / average property, plant and equipment. |
| Inventory turnover | 1.50x | Cost of revenue / average inventory. |
| Days inventory | 243 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 40.6x | Revenue / average receivables. |
| Days sales outstanding | 9 days | 365 x average receivables / revenue. |
| Days payables | 300 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | -48 days | Days inventory + days sales outstanding - days payables. |
| FCF conversion | 81.4% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 34.4% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $3.20 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $22.41 | Revenue / diluted weighted shares. |
| FCF per share | $2.60 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $3.97 | Cash from operations / diluted weighted shares. |
| Book value per share | -$2.25 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | -$3.42 | Tangible book value / shares outstanding. |
| Cash per share | $0.32 | (Cash + short-term investments) / shares outstanding. |
| Buybacks / FCF | 155.5% | Share buybacks / free cash flow, when free cash flow is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $69.66B | Share price x shares outstanding. |
| Enterprise value | $76.42B | Market cap + total debt - cash - short-term investments. |
| P/E | 26.3x | Market cap / net income. Only when net income is positive. |
| P/S | 3.75x | Market cap / revenue. |
| P/FCF | 32.3x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 21.2x | Market cap / cash from operations, when positive. |
| EV/Sales | 4.11x | Enterprise value / revenue. |
| EV/EBIT | 21.0x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 18.3x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 35.4x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 3.1% | Free cash flow / market cap. |
| Earnings yield | 3.8% | Net income / market cap (the inverse of P/E). |
| Shareholder yield | 4.8% | (Dividends paid + share buybacks) / market cap. |
| PEG | 2.60x | P/E / EPS growth per year over 3 years (in percent). Only when both are positive. |
What was O REILLY AUTOMOTIVE INC's revenue in fiscal 2025?
O REILLY AUTOMOTIVE INC reported revenue of $17.78B for fiscal 2025, 6.4% higher than the year before.
Was O REILLY AUTOMOTIVE INC profitable in fiscal 2025?
Yes. Net income was $2.54B, a net margin of 14.3%.
How much free cash flow did O REILLY AUTOMOTIVE INC generate in fiscal 2025?
Cash from operations of $2.76B minus capital expenditures of $1.17B left free cash flow of $1.59B.